Delivery Order SPE2DB20D3505-SPE2DB25FU0A9
Award Date
2/13/25
Potential Completion Date
2/14/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,048.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Irbesartan 300 mg tablets, a medication used to treat high blood pressure. The contract is a Firm Fixed Price Delivery Order with a completion date of January 16, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,432.74, is for the delivery of Irbesartan 300 mg tablets. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,387.56, is for the supply of Irbesartan 300 mg tablets to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,564.06, is for the provision of Irbesartan 300 mg tablets to support federal healthcare programs. It is a Firm Fixed Price contract with a completion date of February 11, 2025. The contract is not designated with a specific set-aside requirement, indicating open competition....
This federal contract award, with a ceiling value of $5,835.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (SPE2DB25FUM55) for the supply of Irbesartan 300 mg tablets, a medication used to treat high blood pressure. The award has an ultimate completion date of February 11, 2025 and was issued on February 10, 2025. There is no set-aside designation for...
This federal contract award, identified as SPE2DB22D2007|SPE2DB25FH7JY, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Irbesartan 150 mg tablets, a cardiovascular medication, with a total ceiling value of $6,617.42 and a completion date of December 4, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,628.89 firm fixed-price delivery order is for the supply of Irbesartan 150 mg tablets. The contract has a period of performance through November 12, 2024 and does not include any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Irbesartan 150 mg tablets. The $5,275.08 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and the vendor's parent company, Cencora, Inc. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive...
This federal contract award is for the delivery of Irbesartan 150 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $2,623.10 and is a Firm Fixed Price Delivery Order contract valid through December 16, 2024. This contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,637.97 Firm Fixed Price Delivery Order is for the supply of 90-count bottles of 300 mg Irbesartan tablets. The contract has an ultimate completion date of November 25, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...